Scholarlink

<p>Systemic lupus erythematosus (SLE) is a chronic, autoimmune disease characterized by multiorgan inflammation due to the dysregulation of the immune system. Despite the availability of conventional immunosuppressive therapies, the management of SLE remains challenging due to treatment resistance and significant side effects. Recent advancements in immunotherapy, particularly chimeric antigen receptor (CAR) T-cell therapy, have shown potential as a novel treatment for autoimmune diseases, including SLE. As of 2025, the treatment landscape for systemic lupus erythematosus (SLE) is undergoing a significant transformation, driven by innovative therapies aiming to provide more effective and potentially curative options for patients. This review provides an overview of the current research on CAR T-cell therapy in SLE, discusses the mechanisms underlying its efficacy, and explores the potential challenges and future directions of this promising therapeutic approach.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Potential of chimeric antigen receptor (CAR) T cell immunotherapy in systemic lupus erythematosus (SLE)

  • 期刊论文

  • 发表日期：

    2026年4月7日

查看全文
  • Ian C. Chikanza,
  • Christina Katsiari,
  • Lazaros I. Sakkas

摘要

Systemic lupus erythematosus (SLE) is a chronic, autoimmune disease characterized by multiorgan inflammation due to the dysregulation of the immune system. Despite the availability of conventional immunosuppressive therapies, the management of SLE remains challenging due to treatment resistance and significant side effects. Recent advancements in immunotherapy, particularly chimeric antigen receptor (CAR) T-cell therapy, have shown potential as a novel treatment for autoimmune diseases, including SLE. As of 2025, the treatment landscape for systemic lupus erythematosus (SLE) is undergoing a significant transformation, driven by innovative therapies aiming to provide more effective and potentially curative options for patients. This review provides an overview of the current research on CAR T-cell therapy in SLE, discusses the mechanisms underlying its efficacy, and explores the potential challenges and future directions of this promising therapeutic approach.